Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 USD | +1.32% |
|
+7.28% | +2.40% |
10/07 | Piper Sandler Adjusts Price Target on Roivant Sciences to $22 From $20, Maintains Overweight Rating | MT |
01/07 | Roivant Sciences Ltd.(NasdaqGS:ROIV) added to Russell 1000 Defensive Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.40% | 8.5B | |
+63.05% | 856B | |
+39.42% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+14.19% | 244B | |
+5.81% | 234B | |
+16.77% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Transcript : Roivant Sciences Ltd. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 02